| Fonds | 2025/Q4 | 2025/Q3 | 2025/Q2 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | |
| 6.819.677 $ | +2.550.138 $ | +32,3 % | 5.259.031 $ | +1.705.414 $ | +18.949,1 % | 2.764.048 $ | +807.700 $ | +33,6 % | |
| Douglass Winthrop Advisors, LLC | 6.496.255 $ | +2.488.558 $ | +62,1 % | 4.007.697 $ | +1.599.811 $ | +66,4 % | 2.407.886 $ | +849.358 $ | +54,5 % |
| MEDICI CAPITAL LLC | 789.569 $ | ||||||||
| Corundum Trust Company, INC | 231.654 $ | +71.752 $ | +44,9 % | 159.902 $ | +18.147 $ | +12,8 % | 141.755 $ | +81.620 $ | +135,7 % |
| Estabrook Capital Management | 91.503 $ | -10.172 $ | -10,0 % | 101.675 $ | -19.075 $ | -15,8 % | 120.750 $ | +1.400 $ | +1,2 % |
| Moloney Securities Asset Management, LLC | 119.647 $ | +26.075 $ | +27,9 % | 93.572 $ | -124.678 $ | -57,1 % | |||
| New England Research & Management, Inc. | 80.541 $ | +80.456 $ | +94.654,1 % | 85 $ | |||||
| Lesa Sroufe & Co | 265 $ | ||||||||
| 6.819.677 $ | +2.550.138 $ | +32,3 % | 5.259.031 $ | +1.705.414 $ | +18.949,1 % | 2.764.048 $ | +807.700 $ | +33,6 % | |